7510 Isocitrate/Isopropylmalate dehydrogenase-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 31 | 10.8 | 2.86× | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 39 | 19.4 | 2.02× | q < 0.0001 | |
| Lipids and lipid-like molecules | 12 | 7.8 | 1.54× | q = 0.18 | |
| Homogeneous metal compounds | 50 | 34.4 | 1.46× | q = 5.7e-4 | |
| Homogeneous non-metal compounds | 14 | 15.1 | 0.93× | q = 0.93 | |
| Benzenoids | 3 | 5.1 | 0.59× | q = 0.57 | |
| Organic oxygen compounds | 5 | 13.9 | 0.36× | q = 0.01 | |
| Organoheterocyclic compounds | 3 | 10.8 | 0.28× | q = 0.01 | |
| Organosulfur compounds | 2 | 1.4 | 1.39× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 194 |
| DB02338 | NDP | NADPH | 119 |
| DB08845 | AKG | Oxogluric acid | 95 |
| DB14128 | NAD | Nadide | 91 |
| DB04279 | IPM | 3-Isopropylmalic Acid | 61 |
| DB00157 | NAI | NADH | 30 |
| DB00131 | AMP | Adenosine phosphate | 19 |
| DB01992 | COA | Coenzyme A | 12 |
| DB16833 | ADP | Adenosine disphosphate | 12 |
| DB02897 | UVW | Acetylphosphate | 9 |
| DB17097 | 9UO | Vorasidenib | 9 |
| DB02175 | MLA | Malonic acid | 8 |
| DB18745 | 7SU | Safusidenib | 8 |
| DB00171 | ATP | ATP | 6 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 6 |
| DB03709 | BCN | Bicine | 5 |
| DB00125 | ARG | Arginine | 4 |
| DB01727 | — | Isocitric Acid | 4 |
| DB03170 | COD | Dephospho Coenzyme A | 4 |
| DB04349 | PGO | (S)-propane-1,2-diol | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 205 |
| ICT | ISOCITRIC ACID | 187 |
| MGmetal | MAGNESIUM ION | 147 |
| CAmetal | CALCIUM ION | 118 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 111 |
| AKG | 2-OXOGLUTARIC ACID | 103 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 90 |
| IPM | 3-ISOPROPYLMALIC ACID | 64 |
| MNmetal | MANGANESE (II) ION | 49 |
| CL | CHLORIDE ION | 48 |
| ZNmetal | ZINC ION | 42 |
| ACO | ACETYL COENZYME *A | 29 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 28 |
| AMP | ADENOSINE MONOPHOSPHATE | 16 |
| EE1 | (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid | 14 |
| NAmetal | SODIUM ION | 14 |
| COA | COENZYME A | 12 |
| DHB | 3,4-DIHYDROXYBENZOIC ACID | 12 |
| SCN | THIOCYANATE ION | 12 |
| ZT3 | N-(4-tert-butylphenyl)-7,8-dimethyl-5,11-dihydro-6H-pyrido[2,3-b][1,5]benzodiazepine-6-carboxamide | 12 |